Electra Therapeutics, Inc. · NASDAQ:ETRA
Parry Graham converted 85,504 Electra Therapeutics, Inc. shares (Form 4)
Traded Sep 21, 2026 · Filed Sep 21, 2026
On Sep 21, 2026, Parry Graham (Chief Scientific Officer) converted 85,504 Electra Therapeutics, Inc. shares, leaving 85,504 shares. Filed Sep 21, 2026 (Form 4).
- Converted
- 85,504 shares
- Holding after
- 85,504 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock | Conversion | 85,504 | 85,504 | Direct |
Source
Related
- Electra Therapeutics, Inc.
- Parry Graham
- Electra Therapeutics, Inc. shareholders
- Schedule 13G · LSP 7 Cooperatief U.A. · Sep 28, 2026
- Schedule 13G · Redmile Group, LLC · Sep 28, 2026
- Schedule 13D · Orbimed Advisors LLC · Sep 25, 2026
- Form 4 · Gordon Carl L · Sep 23, 2026
- Form 4 · Orbimed Capital Gp VII LLC · Sep 23, 2026